CBRE vs EXEL · P/E 43, rev $21.75B vs P/E 17, rev $628.7M
CBRE Group Inc Class A (CBRE) versus Exelixis Inc (EXEL) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Latest reported CBRE revenue for 2026-06-30 was $21.75B. Net income was $522.0M. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
Latest reported EXEL revenue for 2026-07-03 was $628.7M. Net income was $212.1M. Revenue was up 2.9% from 2026-04-03 to 2026-07-03. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Not investment advice. Open the CBRE and EXEL stock pages for the full models.
Not investment advice.